Salvage high-dose chemotherapy for relapsed pure seminoma in the last 10 years: results from the european Society for Blood and Marrow Transplantation Series 2002-2012
The optimal management of advanced seminoma that relapses after chemotherapy remains unknown. We retrospectively analyzed outcomes with the use of high-dose chemotherapy (HDCT)
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2017
|
| In: |
Clinical genitourinary cancer
Year: 2016, Jahrgang: 15, Heft: 1, Pages: 163-167 |
| ISSN: | 1938-0682 |
| DOI: | 10.1016/j.clgc.2016.06.013 |
| Online-Zugang: | Resolving-System, Volltext: http://dx.doi.org/10.1016/j.clgc.2016.06.013 Verlag, Volltext: https://www.sciencedirect.com/science/article/pii/S1558767316301641 
|
| Verfasserangaben: | Andrea Necchi, Salvatore Lo Vullo, Marco Bregni, Giovanni Rosti, Luigi Mariani, Daniele Raggi, Patrizia Giannatempo, Simona Secondino, Kathrin Schumacher, Christophe Massard, Edward Kanfer, Karin Oechsle, Daniele Laszlo, Mariagrazia Michieli, Norbert Ifrah, Melanie Mercier, Martina Crysandt, Patrick Wuchter, Arnon Nagler, Anders Wahlin, Massimo Martino, Manuela Badoglio, Paolo Pedrazzoli, Francesco Lanza |
| Zusammenfassung: | The optimal management of advanced seminoma that relapses after chemotherapy remains unknown. We retrospectively analyzed outcomes with the use of high-dose chemotherapy (HDCT) |
|---|---|
| Beschreibung: | Epub: Jun 27, 2016 Gesehen am 14.09.2018 |
| Beschreibung: | Online Resource |
| ISSN: | 1938-0682 |
| DOI: | 10.1016/j.clgc.2016.06.013 |